
Sign up to save your podcasts
Or


In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:
Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.
He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.
By Rare Cancers AustraliaIn this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:
Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.
He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.

355 Listeners